Ablation Equipments Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Pages: 132 Published: July 29, 2022 Report Code: GDME1406EPD

Ablation Equipments are the devices, used to surgically remove a body tissue. GlobalData's Medical Devices sector report, “Ablation Equipments Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Ablation Equipments pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Ablation Equipments report provides key information and data related to:

Extensive coverage of the Ablation Equipments under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Ablation Equipments pipeline products.

Review of Recent Developments in the segment / industry

The Ablation Equipments report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

Identify and understand important and diverse types of Ablation Equipments under development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Ablation Equipments under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Ablation Equipments and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

– Identify and understand important and diverse types of Ablation Equipments under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Players

Acotec Scientific Holdings Ltd

AngioDynamics Inc

Aqua Medical Inc

Asensus Surgical Inc

Avenda Health Inc

Betters Medical Investment Holdings Ltd

Corveus Medical Inc

Covidien LLC

Covidien Ltd

CPSI Biotech

Creo Medical Ltd

Elesta srl

Endowave Ltd

Eximo Medical Ltd

ExpandoHeat LLC

Fractyl Health Inc

Fuxi Jiuzhen Intelligent Technology (Beijing) Co Ltd

Guangdong Hygeia Medical Devices Manufacturing Co Ltd

Harmonic Medical Inc

HEPTA Medical SASU

Hospital for Special Surgery

Ictero Medical Inc

Integra LifeSciences Holdings Corp

Intratherm LLC (Inactive)

Ionix Medical Inc (Inactive)

I-Vasc Srl

Lepu Scientech Medical Technology (Shanghai) Co Ltd

Massachusetts Institute of Technology

Memorial Sloan Kettering Cancer Center

NaviFUS Corp

NeuroOne Medical Technologies Corp

ProstaCare Pty Ltd

Pulse Biosciences Inc

Sabanci University Nanotechnology Research and Application Center

Shanghai Meili Weiye Medical Technology Co Ltd

Southern Illinois University Carbondale

Symple Surgical Inc

Thermedical Inc

University of California San Francisco

University of Georgia

University of Texas at Austin

University of Wisconsin-Stout

Table of Contents

1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 11

2 Introduction 12

2.1 Ablation Equipments Overview 12

3 Products under Development 13

3.1 Ablation Equipments – Pipeline Products by Stage of Development 13

3.2 Ablation Equipments – Pipeline Products by Territory 14

3.3 Ablation Equipments – Pipeline Products by Regulatory Path 15

3.4 Ablation Equipments – Pipeline Products by Estimated Approval Date 16

3.5 Ablation Equipments – Ongoing Clinical Trials 17

4 Ablation Equipments – Pipeline Products under Development by Companies 18

4.1 Ablation Equipments Companies – Pipeline Products by Stage of Development 18

4.2 Ablation Equipments – Pipeline Products by Stage of Development 20

5 Ablation Equipments Companies and Product Overview 22

5.1 Acotec Scientific Holdings Ltd Company Overview 22

5.1.1 Acotec Scientific Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

5.2 AngioDynamics Inc Company Overview 23

5.2.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 23

5.3 Aqua Medical Inc Company Overview 39

5.3.1 Aqua Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 39

5.4 Asensus Surgical Inc Company Overview 42

5.4.1 Asensus Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.5 Avenda Health Inc Company Overview 43

5.5.1 Avenda Health Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.6 Betters Medical Investment Holdings Ltd Company Overview 46

5.6.1 Betters Medical Investment Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

5.7 Corveus Medical Inc Company Overview 53

5.7.1 Corveus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 53

5.8 Covidien LLC Company Overview 54

5.8.1 Covidien LLC Pipeline Products & Ongoing Clinical Trials Overview 54

5.9 Covidien Ltd Company Overview 55

5.9.1 Covidien Ltd Pipeline Products & Ongoing Clinical Trials Overview 55

5.10 CPSI Biotech Company Overview 56

5.10.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 56

5.11 Creo Medical Ltd Company Overview 58

5.11.1 Creo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

5.12 Elesta srl Company Overview 59

5.12.1 Elesta srl Pipeline Products & Ongoing Clinical Trials Overview 59

5.13 Endowave Ltd Company Overview 63

5.13.1 Endowave Ltd Pipeline Products & Ongoing Clinical Trials Overview 63

5.14 Eximo Medical Ltd Company Overview 64

5.14.1 Eximo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

5.15 ExpandoHeat LLC Company Overview 65

5.15.1 ExpandoHeat LLC Pipeline Products & Ongoing Clinical Trials Overview 65

5.16 Fractyl Health Inc Company Overview 66

5.16.1 Fractyl Health Inc Pipeline Products & Ongoing Clinical Trials Overview 66

5.17 Fuxi Jiuzhen Intelligent Technology (Beijing) Co Ltd Company Overview 69

5.17.1 Fuxi Jiuzhen Intelligent Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 69

5.18 Guangdong Hygeia Medical Devices Manufacturing Co Ltd Company Overview 70

5.18.1 Guangdong Hygeia Medical Devices Manufacturing Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 70

5.19 Harmonic Medical Inc Company Overview 71

5.19.1 Harmonic Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 71

5.20 HEPTA Medical SASU Company Overview 74

5.20.1 HEPTA Medical SASU Pipeline Products & Ongoing Clinical Trials Overview 74

5.21 Hospital for Special Surgery Company Overview 75

5.21.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview 75

5.22 Ictero Medical Inc Company Overview 76

5.22.1 Ictero Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 76

5.23 Integra LifeSciences Holdings Corp Company Overview 77

5.23.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 77

5.24 Intratherm LLC (Inactive) Company Overview 79

5.24.1 Intratherm LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 79

5.25 Ionix Medical Inc (Inactive) Company Overview 80

5.25.1 Ionix Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 80

5.26 I-Vasc Srl Company Overview 81

5.26.1 I-Vasc Srl Pipeline Products & Ongoing Clinical Trials Overview 81

5.27 Lepu Scientech Medical Technology (Shanghai) Co Ltd Company Overview 84

5.27.1 Lepu Scientech Medical Technology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 84

5.28 Massachusetts Institute of Technology Company Overview 85

5.28.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 85

5.29 Memorial Sloan Kettering Cancer Center Company Overview 86

5.29.1 Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 86

5.30 NaviFUS Corp Company Overview 88

5.30.1 NaviFUS Corp Pipeline Products & Ongoing Clinical Trials Overview 88

5.31 NeuroOne Medical Technologies Corp Company Overview 89

5.31.1 NeuroOne Medical Technologies Corp Pipeline Products & Ongoing Clinical Trials Overview 89

5.32 ProstaCare Pty Ltd Company Overview 91

5.32.1 ProstaCare Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 91

5.33 Pulse Biosciences Inc Company Overview 92

5.33.1 Pulse Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 92

5.34 Sabanci University Nanotechnology Research and Application Center Company Overview 93

5.34.1 Sabanci University Nanotechnology Research and Application Center Pipeline Products & Ongoing Clinical Trials Overview 93

5.35 Shanghai Meili Weiye Medical Technology Co Ltd Company Overview 94

5.35.1 Shanghai Meili Weiye Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 94

5.36 Southern Illinois University Carbondale Company Overview 95

5.36.1 Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview 95

5.37 Symple Surgical Inc Company Overview 96

5.37.1 Symple Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 96

5.38 Thermedical Inc Company Overview 97

5.38.1 Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview 97

5.39 University of California San Francisco Company Overview 98

5.39.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 98

5.40 University of Georgia Company Overview 99

5.40.1 University of Georgia Pipeline Products & Ongoing Clinical Trials Overview 99

5.41 University of Texas at Austin Company Overview 100

5.41.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 100

5.42 University of Wisconsin-Stout Company Overview 101

5.42.1 University of Wisconsin-Stout Pipeline Products & Ongoing Clinical Trials Overview 101

6 Ablation Equipments- Recent Developments 102

6.1 Jul 12, 2022: AtriCure to Announce Second Quarter 2022 Financial Results 102

6.2 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director 102

6.3 Jun 01, 2022: AtriCure Announces the Appointment of Deborah Yount as Chief Human Resources Officer 103

6.4 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results 103

6.5 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase 103

6.6 Apr 28, 2022: Smith+Nephew First Quarter 2022 Trading Update 103

6.7 Apr 18, 2022: HSS Appoints New Chief Nurse Executive 105

6.8 Apr 11, 2022: AtriCure to Announce First Quarter 2022 Financial Results 106

6.9 Apr 08, 2022: Olympus completes spin-out of Scientific Solutions business 106

6.10 Mar 31, 2022: Smith & Nephew announces Directorate Change 106

6.11 Mar 24, 2022: HSS Presents New Biomechanics Research at 2022 AAOS Annual Meeting 107

6.12 Mar 07, 2022: Smith & Nephew Announces Notice of Annual General Meeting 108

6.13 Mar 07, 2022: Smith & Nephew Notice of 85th Annual General Meeting 109

6.14 Feb 22, 2022: Smith+nephew Announces New Chief Executive Officer 110

6.15 Feb 03, 2022: Memorial Sloan Kettering President and CEO Craig B. Thompson, MD to Step Down 114

6.16 Jan 11, 2022: Integra LifeSciences Reports Preliminary Fourth Quarter and Full-Year 2021 Revenue and Plans $125 Million Share Repurchase 114

6.17 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference 115

6.18 Dec 23, 2021: Olympus to Present at JP Morgan Healthcare Conference 116

6.19 Dec 22, 2021: Pioneering Physician-Scientist Timothy B. Niewold, MD, FACR Appointed Vice Chair for Research in the Department of Medicine at Hospital for Special Surgery (HSS) 116

6.20 Dec 16, 2021: HSS Names Michael P. Ast, MD, Vice-Chair and Chief Medical Innovation Officer 117

6.21 Nov 18, 2021: CLS Again releases TRANBERG sterile disposable products into the US Market 118

6.22 Sep 02, 2021: Integra LifeSciences Announces Participation In Upcoming Investor Conferences 118

6.23 Aug 23, 2021: NeuroOne announces strategic partnership with RBC medical innovations for ablation program 119

6.24 Aug 05, 2021: Olympus Announces Consolidated Financial Results for the Three Months of the Fiscal Year Ending March 31, 2022 119

6.25 Aug 04, 2021: AtriCure Reports Second Quarter 2021 Financial Results 119

6.26 Jul 30, 2021: AtriCure to Participate at the Canaccord 41st Annual Growth Conference 120

6.27 Jul 29, 2021: Smith+Nephew Second Quarter and First Half 2021 Results 120

6.28 Jul 29, 2021: Misonix Reports Preliminary Fiscal 2021 Fourth Quarter and Full Year Revenue Results 121

6.29 Jul 29, 2021: Smith & Nephew announces Half-year Report 123

6.30 Jul 28, 2021: Integra LifeSciences Reports Second Quarter 2021 Financial Results 124

6.31 Jul 27, 2021: Stryker reports second quarter 2021 operating results 127

7 Appendix 129

7.1 Methodology 129

7.2 About GlobalData 132

7.3 Contact Us 132

7.4 Disclaimer 132

List of Tables

Ablation Equipments – Pipeline Products by Stage of Development 13

Ablation Equipments – Pipeline Products by Territory 14

Ablation Equipments – Pipeline Products by Regulatory Path 15

Ablation Equipments – Pipeline Products by Estimated Approval Date 16

Ablation Equipments – Ongoing Clinical Trials 17

Ablation Equipments Companies – Pipeline Products by Stage of Development 18

Ablation Equipments – Pipeline Products by Stage of Development 20

Acotec Scientific Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

Radiofrequency Ablation System – Product Status 22

Radiofrequency Ablation System – Product Description 22

AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 23

Nanoknife System – Bladder Cancer – Product Status 23

Nanoknife System – Bladder Cancer – Product Description 24

NanoKnife System – Cervical Cancer – Product Status 24

NanoKnife System – Cervical Cancer – Product Description 24

NanoKnife System – Head And Neck Cancer – Product Status 25

NanoKnife System – Head And Neck Cancer – Product Description 25

NanoKnife System – Hepatocellular Carcinoma – Product Status 25

NanoKnife System – Hepatocellular Carcinoma – Product Description 26

NanoKnife System – Lung Cancer – Product Status 26

NanoKnife System – Lung Cancer – Product Description 27

Nanoknife System – Metastatic Lymph Nodes – Product Status 27

Nanoknife System – Metastatic Lymph Nodes – Product Description 28

NanoKnife System – Prostate Cancer – Product Status 28

NanoKnife System – Prostate Cancer – Product Description 29

NanoKnife System – Rectal Cancer – Product Status 29

NanoKnife System – Rectal Cancer – Product Description 29

Nanoknife System – Renal Pelvis Urothelial Neoplasms – Product Status 30

Nanoknife System – Renal Pelvis Urothelial Neoplasms – Product Description 30

NanoKnife System – Stage III Pancreatic Cancer – Product Status 31

NanoKnife System – Stage III Pancreatic Cancer – Product Description 31

Nanoknife System – Stomach Neoplasm – Product Status 31

Nanoknife System – Stomach Neoplasm – Product Description 32

POWERWAVE – Product Status 32

POWERWAVE – Product Description 32

AngioDynamics Inc – Ongoing Clinical Trials Overview 33

NanoKnife System – Prostate Cancer – Examination of Focal Therapies – MRI-Fusion, HIFU, NanoKnife and Cryotherapy 34

NanoKnife System – Prostate Cancer – Focal Irreversible Electroporation as Salvage Treatment in Radio-recurrent Prostate Cancer: A Prospective Multicenter Pilot Study 34

NanoKnife System – Prostate Cancer – Irreversible Electroporation in Combination with Immune Checkpoint Inhibition, in Patients with Metastatic Pancreatic Cancer – A Prospective, Phase 2 Study 34

NanoKnife System – Prostate Cancer – Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue in an Intermediate-risk Patient Population 35

NanoKnife System – Prostate Cancer – Registry of Irreversible Electroporation for the Ablation of Prostate Cancer with Use of Nanoknife Device; A Multi-center, International Registry to Evaluate the Treatment of Prostate Cancer in Terms of Recurrence, Functional Outcomes and Safety 35

NanoKnife System – Stage III Pancreatic Cancer – A Randomized, Multicenter, Controlled, Unblinded Study to Assess the Safety and Efficacy of the NanoKnife System for the Ablation of Unresectable Stage 3 Pancreatic Adenocarcinoma 36

NanoKnife System – Stage III Pancreatic Cancer – Ablation of Unresectable Locally Advanced Pancreatic Cancer with Nanoknife Irreversible Electroporation (IRE) System: Response and Tolerability 36

NanoKnife System – Stage III Pancreatic Cancer – An Open-label, Multicenter, Prospective Study of Irreversible Electroporation (Nano Knife) Combined with Radiotherapy and Chemotherapy in Patients with Locally Advanced Pancreatic Cancer 36

NanoKnife System – Stage III Pancreatic Cancer – Assessing Optimal Treatment Settings for the Ablation of Locally Advanced Pancreatic Cancer with CT-guided Percutaneous Irreversible Electroporation (ANTILOPE): A Randomized Feasibility Study 37

NanoKnife System – Stage III Pancreatic Cancer – Irreversible Electroporation for Locally Advanced Pancreatic Ductal Adenocarcinoma (LEAP TRIAL): A Phase I/II Prospective Trial 37

NanoKnife System – Stage III Pancreatic Cancer – Registry to Evaluate Effectiveness and Safety of the NanoKnife System for the Ablation of Stage 3 Pancreatic Adenocarcinoma 37

NanoKnife System – Stage III Pancreatic Cancer – Systemic Therapy with a Loco-regional Treatment in Patients with Locally Advanced Pancreatic Cancer: The SMART Study 38

Aqua Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 39

Radio Frequency Vapor Ablation (RFVA) System – Precancerous Pancreatic Cysts – Product Status 39

Radio Frequency Vapor Ablation (RFVA) System – Precancerous Pancreatic Cysts – Product Description 39

Radio Frequency Vapor Ablation (RFVA) System – Pulmonary Tissue Ablation – Product Status 40

Radio Frequency Vapor Ablation (RFVA) System – Pulmonary Tissue Ablation – Product Description 40

Radio Frequency Vapor Ablation (RFVA) System – Type 2 Diabetes – Product Status 40

Radio Frequency Vapor Ablation (RFVA) System – Type 2 Diabetes – Product Description 41

Asensus Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 42

Barrett's Excision Device – Product Status 42

Barrett's Excision Device – Product Description 42

Avenda Health Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Orion System – Product Status 43

Orion System – Product Description 43

Avenda Health Inc – Ongoing Clinical Trials Overview 44

Orion System – Office-based Focal Laser Ablation of Prostate Cancer: An Early Feasibility Study Using MRI/US Image Fusion for Guidance 45

Betters Medical Investment Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

Endoscope-Guided Puncture MWA Needle – Product Status 46

Endoscope-Guided Puncture MWA Needle – Product Description 47

Microwave Ablation Catheter – Product Status 47

Microwave Ablation Catheter – Product Description 47

Microwave Ablation Therapeutic Apparatus – Bone Tumours – Product Status 48

Microwave Ablation Therapeutic Apparatus – Bone Tumours – Product Description 48

Microwave Ablation Therapeutic Apparatus – Breast Lump – Product Status 48

Microwave Ablation Therapeutic Apparatus – Breast Lump – Product Description 49

Microwave Ablation Therapeutic Apparatus – Pulmonary Nodule – Product Status 49

Microwave Ablation Therapeutic Apparatus – Pulmonary Nodule – Product Description 49

Microwave Ablation Therapeutic Apparatus – Uterine Fibroids – Product Status 50

Microwave Ablation Therapeutic Apparatus – Uterine Fibroids – Product Description 50

MTI-5FT 915 MHz MWA Therapeutic Apparatus – Product Status 50

MTI-5FT 915 MHz MWA Therapeutic Apparatus – Product Description 51

MTI-5GT Four-Source MWA Therapeutic Apparatus – Product Status 51

MTI-5GT Four-Source MWA Therapeutic Apparatus – Product Description 52

MWA-Ultrasound Integrated Therapeutic Apparatus – Product Status 52

MWA-Ultrasound Integrated Therapeutic Apparatus – Product Description 52

Corveus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 53

Nerve Ablation Catheter – Product Status 53

Nerve Ablation Catheter – Product Description 53

Covidien LLC Pipeline Products & Ongoing Clinical Trials Overview 54

Emprint Ablation Catheter Kit – Product Status 54

Emprint Ablation Catheter Kit – Product Description 54

Covidien Ltd Pipeline Products & Ongoing Clinical Trials Overview 55

Evident MWA System – Lung Tumors – Product Status 55

Evident MWA System – Lung Tumors – Product Description 55

CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 56

Pressurized Sub-Cooled Nitrogen System – Product Status 56

Pressurized Sub-Cooled Nitrogen System – Product Description 56

Super-Critical Nitrogen (SCN) Cryoablation Device – Product Status 57

Super-Critical Nitrogen (SCN) Cryoablation Device – Product Description 57

Creo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

Flexible Ablation System – Product Status 58

Flexible Ablation System – Product Description 58

Elesta srl Pipeline Products & Ongoing Clinical Trials Overview 59

EchoLaser EVO SoracteLite – Product Status 59

EchoLaser EVO SoracteLite – Product Description 59

EchoLaser X4 – Product Status 60

EchoLaser X4 – Product Description 60

Elesta srl – Ongoing Clinical Trials Overview 61

EchoLaser EVO SoracteLite – Soractelite Transperineal Laser Ablation for Benign Prostatic Hyperplasia with Bladder Outlet Obstruction 62

EchoLaser EVO SoracteLite – Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia: A Feasibility Study – Results at 6 and 12 Months From a Retrospective Multi-centric Study 62

Endowave Ltd Pipeline Products & Ongoing Clinical Trials Overview 63

Microwave Ablation Catheter – Lung Cancer – Product Status 63

Microwave Ablation Catheter – Lung Cancer – Product Description 63

Eximo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

AURYON Atherectomy System – Gastrointestinal Procedures – Product Status 64

AURYON Atherectomy System – Gastrointestinal Procedures – Product Description 64

ExpandoHeat LLC Pipeline Products & Ongoing Clinical Trials Overview 65

Catheter Device – Tissue Ablation – Product Status 65

Catheter Device – Tissue Ablation – Product Description 65

Fractyl Health Inc Pipeline Products & Ongoing Clinical Trials Overview 66

Revita DMR System – Product Status 66

Revita DMR System – Product Description 66

Fractyl Health Inc – Ongoing Clinical Trials Overview 67

Revita DMR System – A Prospective, Randomized, Double-blind, Sham-controlled, Multi-center Pivotal Study to Evaluate the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita System in Subjects with Type 2 Diabetes on Insulin Therapy 68

Revita DMR System – Pivotal Study to Evaluate the Efficacy of Revita DMR System in Patients with Type 2 Diabetes (T2D): Revitalize-2 68

Fuxi Jiuzhen Intelligent Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 69

Tumor Ablation Puncture Robot – Product Status 69

Tumor Ablation Puncture Robot – Product Description 69

Guangdong Hygeia Medical Devices Manufacturing Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 70

Cold and Heat Ablation System – Product Status 70

Cold and Heat Ablation System – Product Description 70

Harmonic Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 71

Symphony MRI guided High Intensity Focused Ultrasound – Leiomyomas – Product Status 71

Symphony MRI guided High Intensity Focused Ultrasound – Leiomyomas – Product Description 71

Harmonic Medical Inc – Ongoing Clinical Trials Overview 72

Symphony MRI guided High Intensity Focused Ultrasound – Leiomyomas – MRI-guided High Intensity Focused Ultrasound Ablation of Leiomyomas. Single Arm, Feasibility Study Using the Symphony – MRI Guided Focused Ultrasound System for the Treatment of Leiomyomas 73

HEPTA Medical SASU Pipeline Products & Ongoing Clinical Trials Overview 74

Ablation Catheter – Lung Cancer – Product Status 74

Ablation Catheter – Lung Cancer – Product Description 74

Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview 75

Radiofrequency Ablation Device – Product Status 75

Radiofrequency Ablation Device – Product Description 75

Ictero Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 76

CholeSafe System – Product Status 76

CholeSafe System – Product Description 76

Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 77

CUSA Accessories – Product Status 77

CUSA Accessories – Product Description 77

CUSA Ultrasonic Tissue Ablation System – Liver – Product Status 78

CUSA Ultrasonic Tissue Ablation System – Liver – Product Description 78

Intratherm LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 79

CITT Device – Product Status 79

CITT Device – Product Description 79

Ionix Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 80

Neuflo System – Product Status 80

Neuflo System – Product Description 80

I-Vasc Srl Pipeline Products & Ongoing Clinical Trials Overview 81

VELEX – Product Status 81

VELEX – Product Description 81

I-Vasc Srl – Ongoing Clinical Trials Overview 82

VELEX – A Post-Market Clinical Study of VELEX in Treatment of Chronic Venous Insufficiency 83

Lepu Scientech Medical Technology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 84

Radiofrequency Ablation Device – Product Status 84

Radiofrequency Ablation Device – Product Description 84

Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 85

Image Guided Endoscopic Ablation Device – Product Status 85

Image Guided Endoscopic Ablation Device – Product Description 85

Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 86

Image-Guided Ablation Device – Product Status 86

Image-Guided Ablation Device – Product Description 86

Image-Guided Ablation Device – Pancreatic And Bile Duct Cancer – Product Status 87

Image-Guided Ablation Device – Pancreatic And Bile Duct Cancer – Product Description 87

NaviFUS Corp Pipeline Products & Ongoing Clinical Trials Overview 88

NAVIRFA Scope – Product Status 88

NAVIRFA Scope – Product Description 88

NeuroOne Medical Technologies Corp Pipeline Products & Ongoing Clinical Trials Overview 89

RF Ablation Therapeutic System – Product Status 89

RF Ablation Therapeutic System – Product Description 89

Therapeutic Electrode – Brain Tissue Ablation – Product Status 90

Therapeutic Electrode – Brain Tissue Ablation – Product Description 90

ProstaCare Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 91

ProstaFix System – Product Status 91

ProstaFix System – Product Description 91

Pulse Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 92

PulseTx System – Soft Tissue Ablation – Product Status 92

PulseTx System – Soft Tissue Ablation – Product Description 92

Sabanci University Nanotechnology Research and Application Center Pipeline Products & Ongoing Clinical Trials Overview 93

Ultrasonic Cavitation Device – BPH – Product Status 93

Ultrasonic Cavitation Device – BPH – Product Description 93

Shanghai Meili Weiye Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 94

Percutaneous Intravascular Radiofrequency Nerve Ablation Device – Product Status 94

Percutaneous Intravascular Radiofrequency Nerve Ablation Device – Product Description 94

Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview 95

Thermoablation Probe – Product Status 95

Thermoablation Probe – Product Description 95

Symple Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 96

DirectAblate Grizzly Microwave Ablation Catheter – Product Status 96

DirectAblate Grizzly Microwave Ablation Catheter – Product Description 96

Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview 97

SERF Ablation System – Fibroids – Product Status 97

SERF Ablation System – Fibroids – Product Description 97

University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 98

Robotic Needle Ablation Tool And Securement Device – Product Status 98

Robotic Needle Ablation Tool And Securement Device – Product Description 98

University of Georgia Pipeline Products & Ongoing Clinical Trials Overview 99

Radiofrequency Tissue Ablation System – Product Status 99

Radiofrequency Tissue Ablation System – Product Description 99

University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 100

Plasmonic Laser Ablation Device – Product Status 100

Plasmonic Laser Ablation Device – Product Description 100

University of Wisconsin-Stout Pipeline Products & Ongoing Clinical Trials Overview 101

Microwave Ablation Probe – Product Status 101

Microwave Ablation Probe – Product Description 101

Glossary 131

List of Figures

Ablation Equipments – Pipeline Products by Stage of Development 13

Ablation Equipments – Pipeline Products by Territory 14

Ablation Equipments – Pipeline Products by Regulatory Path 15

Ablation Equipments – Pipeline Products by Estimated Approval Date 16

Ablation Equipments – Ongoing Clinical Trials 17

Frequently Asked Questions

Request a Free Sample
$4000

Can be used by individual purchaser only

$12000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.